Dianthus Therapeutics (DNTH) Return on Sales (2022 - 2025)
Dianthus Therapeutics (DNTH) has 4 years of Return on Sales data on record, last reported at 103.13% in Q3 2025.
- For Q3 2025, Return on Sales fell 9141.0% year-over-year to 103.13%; the TTM value through Sep 2025 reached 16.37%, down 380.0%, while the annual FY2024 figure was 13.55%, 181.0% up from the prior year.
- Return on Sales reached 103.13% in Q3 2025 per DNTH's latest filing, up from 169.03% in the prior quarter.
- Across five years, Return on Sales topped out at 4.48% in Q4 2024 and bottomed at 169.03% in Q2 2025.
- Average Return on Sales over 4 years is 34.43%, with a median of 14.87% recorded in 2024.
- Peak YoY movement for Return on Sales: skyrocketed 2020bps in 2024, then plummeted -15963bps in 2025.
- A 4-year view of Return on Sales shows it stood at 8.68% in 2022, then crashed by -184bps to 24.68% in 2023, then soared by 82bps to 4.48% in 2024, then tumbled by -2203bps to 103.13% in 2025.
- Per Business Quant database, its latest 3 readings for Return on Sales were 103.13% in Q3 2025, 169.03% in Q2 2025, and 25.27% in Q1 2025.